SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

08 Feb 2022 Evaluate
The December 2021 quarter revenue stood at Rs. 8897.79 millions, up 14.66% as compared to Rs. 7760.11 millions during the corresponding quarter last year.A slender decline of -7.42% was recorded to Rs. 1213.29  millions from Rs. 1310.55 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 1968.24 millions from 2043.16 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 8897.79 7760.11 14.66 23255.89 23534.31 -1.18 31349.82 23099.28 35.72
Other Income 47.85 29.49 62.26 164.24 123.24 33.27 137.23 264.57 -48.13
PBIDT 1968.24 2043.16 -3.67 4519.12 6491.20 -30.38 8750.96 5205.94 68.10
Interest 29.56 59.42 -50.25 123.52 180.21 -31.46 237.74 268.62 -11.50
PBDT 1938.68 1983.74 -2.27 4395.60 6310.99 -30.35 8513.22 6548.51 30.00
Depreciation 311.27 297.70 4.56 944.79 879.40 7.44 1184.51 1018.24 16.33
PBT 1627.41 1686.04 -3.48 3450.81 5431.59 -36.47 7328.71 5530.27 32.52
TAX 414.12 375.49 10.29 878.11 1326.28 -33.79 1800.87 1089.57 65.28
Deferred Tax -7.17 -8.96 -19.98 -15.20 -176.20 -91.37 -169.74 -132.70 27.91
PAT 1213.29 1310.55 -7.42 2572.70 4105.31 -37.33 5527.84 4440.70 24.48
Equity 248.01 247.68 0.13 248.01 247.68 0.13 247.68 254.25 -2.58
PBIDTM(%) 22.12 26.33 -15.98 19.43 27.58 -29.55 27.91 22.54 23.86

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×